PenRad’s High-Risk Breast Clinic module offers a comprehensive solution for patients and clinicians. Automated breast cancer risk assessment, genetic testing eligibility, insurance authorization, patient education, data management and more, are all included in this offering.
PenRad’s High-Risk Breast Clinic module improves client and patient satisfaction and can increase client revenue. This module automatically computes breast cancer risk values by factoring in breast density and the seven types of patient and relatives’ cancer incidence, plus BRCA findings. Genetic testing is the ultimate risk identifier, factoring in multiple cancer types for patients and their relatives
Leveraging the Tyrer Cuzick algorithm, this module automatically references a patient’s breast density, patient and familial breast and ovarian cancer history and BRCA findings to calculate the breast cancer risk value.
PenRad automates the identification of high-risk patients and the dissemination of their data to the appropriate personnel.
Administrative Reports: Mine your existing patient data for those possibly at high risk, potential BRCA testing, track patient status, and provide an opportunity to request more information for genetic testing.
Pair the High-Risk Breast Module with PenXpress and PenForms to collect patient information prior to the exam, reducing the patient’s anxiety and minimizing manual data entry.
Referring Physician Notification: Automatically provide breast cancer risk scores, genetic testing eligibility, and provide guidelines for additional exams based on risk factors.
Optimize Insurance Pre-authorization: Automatically create documents that include high-risk data for approval of advanced imaging procedures and genetic testing eligibility.
Prior to a patient’s appointment send them a web link via PenXpress to complete or update their medical and risk information.
Should patients opt to complete their risk survey or update their genetic testing eligibility in the clinic, once the survey is completed, automatic messaging about computed breast cancer risk scores and genetic testing eligibility becomes available.
Automate patient medical and risk data updates while automatically factoring breast density values, saving your clinic time to focus on what matters most: providing your patients with outstanding care.
PenRad’s products are supported by PenCare, a proactive and dedicated support platform committed to customer service. PenCare can provide: software platform enhancements, regulatory updates, industry information, software training, patient needs support, structured report generation, letter template support and more.
© 2021 Intelerad Medical Systems Incorporated. All rights reserved.